Abstract
The molecular diversity of bovine τ obtained by three different preparation protocols was characterized by immunoblot analyses after two-dimensional gel electrophoresis. These analyses revealed that t was heterogeneously modified, that is, up to 20 spots separated along the pH gradient, mostly independent of the preparation protocol.
Keywords: Alzheimer's disease, mass spectrometry, PHF-τ, phosphoprotein stain, phosphorylation, septin
Protein & Peptide Letters
Title: Characterization of Bovine Tau-Preparations by Two-Dimensional Gel Electrophoresis
Volume: 13 Issue: 6
Author(s): Daniela Volke and Ralf Hoffmann
Affiliation:
Keywords: Alzheimer's disease, mass spectrometry, PHF-τ, phosphoprotein stain, phosphorylation, septin
Abstract: The molecular diversity of bovine τ obtained by three different preparation protocols was characterized by immunoblot analyses after two-dimensional gel electrophoresis. These analyses revealed that t was heterogeneously modified, that is, up to 20 spots separated along the pH gradient, mostly independent of the preparation protocol.
Export Options
About this article
Cite this article as:
Volke Daniela and Hoffmann Ralf, Characterization of Bovine Tau-Preparations by Two-Dimensional Gel Electrophoresis, Protein & Peptide Letters 2006; 13 (6) . https://dx.doi.org/10.2174/092986606777145805
DOI https://dx.doi.org/10.2174/092986606777145805 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Systemic Drugs: A Critical Review
Current Pharmaceutical Design Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Current Pharmaceutical Design Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Mitochondria in Chronic Liver Disease
Current Drug Targets Bone Marrow Reconstitution as a Relevant Model of Genetically Programmed Leukemia
Current Medicinal Chemistry - Cardiovascular & Hematological Agents P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Drug Metabolism Letters An Erythroid-Enriched Endoribonuclease (ErEN) Involved in α -Globin mRNA Turnover
Protein & Peptide Letters Alcohol Abuse, Immunosuppression, and Pulmonary Infection
Current Drug Abuse Reviews miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Peroxynitrite-Driven Mechanisms in Diabetes and Insulin Resistance – the Latest Advances
Current Medicinal Chemistry Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Current Pharmaceutical Design Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Review Metabolomics: A New Approach to Drug Delivery in Perinatology
Current Medicinal Chemistry Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
Current Medicinal Chemistry Therapeutic Targets in the Ubiquitin-proteasome System for Alzheimer's Disease
Current Enzyme Inhibition